Eagle Global Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,700
| Closed | -$283K | – | 228 |
|
|
2023
Q1 | $283K | Hold |
4,700
| – | – | 0.02% | 193 |
|
|
2022
Q4 | $345K | Hold |
4,700
| – | – | 0.02% | 183 |
|
|
2022
Q3 | $357K | Hold |
4,700
| – | – | 0.03% | 177 |
|
|
2022
Q2 | $327K | Sell |
4,700
-1,000
| -18% | -$69.6K | 0.02% | 185 |
|
|
2022
Q1 | $472K | Sell |
5,700
-1,400
| -20% | -$116K | 0.03% | 177 |
|
|
2021
Q4 | $533K | Hold |
7,100
| – | – | 0.03% | 173 |
|
|
2021
Q3 | $825K | Buy |
7,100
+2,400
| +51% | +$279K | 0.05% | 152 |
|
|
2021
Q2 | $1.04M | Hold |
4,700
| – | – | 0.07% | 143 |
|
|
2021
Q1 | $621K | Hold |
4,700
| – | – | 0.05% | 172 |
|
|
2020
Q4 | $813K | Hold |
4,700
| – | – | 0.06% | 142 |
|
|
2020
Q3 | $523K | Buy |
+4,700
| New | +$523K | 0.05% | 146 |
|